Business Description
Biotron Ltd
ISIN : AU000000BIT4
Total Employee Number:
4Description
Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.7 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year FCF Growth Rate | 30.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 80.52 | |||||
9-Day RSI | 35.25 | |||||
14-Day RSI | 17.62 | |||||
3-1 Month Momentum % | -96.58 | |||||
6-1 Month Momentum % | -94.9 | |||||
12-1 Month Momentum % | -88.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.47 | |||||
Quick Ratio | 1.47 | |||||
Cash Ratio | 1.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17 | |||||
Shareholder Yield % | -33.84 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -156.55 | |||||
ROA % | -100.1 | |||||
ROIC % | -159.84 | |||||
3-Year ROIIC % | 438.96 | |||||
ROC (Joel Greenblatt) % | -34341.18 | |||||
ROCE % | -157.4 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 3 | |||||
EV-to-EBIT | -3.97 | |||||
EV-to-EBITDA | -3.98 | |||||
EV-to-FCF | -4.01 | |||||
Earnings Yield (Greenblatt) % | -25.19 | |||||
FCF Yield % | -23.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BITRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biotron Ltd Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.001 | ||
| Beta | -6.8602 | ||
| 3-Year Sharpe Ratio | 0.89 | ||
| 3-Year Sortino Ratio | 5.92 | ||
| Volatility % | 1272.58 | ||
| 14-Day RSI | 17.62 | ||
| 14-Day ATR ($) | 0.000203 | ||
| 20-Day SMA ($) | 0.00155 | ||
| 12-1 Month Momentum % | -88.42 | ||
| 52-Week Range ($) | 0.0011 - 0.10144 | ||
| Shares Outstanding (Mil) | 2,701.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biotron Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biotron Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biotron Ltd Frequently Asked Questions
What is Biotron Ltd(BITRF)'s stock price today?
The current price of BITRF is $0.00. The 52 week high of BITRF is $0.10 and 52 week low is $0.00.
When is next earnings date of Biotron Ltd(BITRF)?
The next earnings date of Biotron Ltd(BITRF) is .
Does Biotron Ltd(BITRF) pay dividends? If so, how much?
Biotron Ltd(BITRF) does not pay dividend.
Guru Commentaries on OTCPK:BITRF
No articles.
Articles on Biotron Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers